Following three years of internal development, Expedition Medicines is taking flight. The company is supported by a $50 ...
According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...
Natural products derived from microorganisms are a promising source of new active ingredients, but are often produced only in ...
The U.S. Cell-based Assays Market is Expanding Rapidly Due to Strong Pharmaceutical Activity, Technological Innovation, and Increasing Use in Drug Discovery and Toxicity Testing.Austin, Oct. 30, 2025 ...
WuXi AppTec, a global contract research, development, and manufacturing organization (CRDMO), recently hosted its 2025 ...
On October 27, Thermo Fisher Scientific and Lundbeck both announced new collaborations with OpenAI. These moves represent a continuing trend of drug development companies inking deals with technology ...
SandboxAQ, a U.S.-based artificial intelligence and quantum technology firm, signed an agreement with Bahrain's sovereign ...
The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity ...
News Medical on MSN
Cyclana Bio Raises £5M to Advance Drug Discovery for Endometriosis
Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women’s health, today announced the close of a £5M ...
Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback